Companies / NYR

NYRADA INC.

ASX:NYRPharmaceuticals, Biotechnology & Life Sciences
258.7M shares on issueASX (delayed) · snapshot 28 Oct 2026303.8M fully diluted+17.4% if every option and right converts$0.49price · delayed$125.5MMarket capAt the previous close. On a day the price moves, shares × today’s price will differ. Prices delayed.

Today’s holders own 85.1% of what they think they own, once every option and right converts.

Moderate
Dilution risk

Share count grew 42% in 24 months; 2 cash raises in 24 months; options/rights overhang 17% of shares

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway10.9 quarters of funding
Share-count growth (24m)42.0%
Raise cadence (24m)2 cash raises
Options & rights overhang17.4% of shares
In-the-money supply6.8% of shares
Pending proposed issuesopen proposed issue (Appendix 3B)

NYRADA INC.'s ordinary share count grew 42.0% between June 2024 and September 2026, its latest share-count filing, to 259M shares. The company raised capital twice in the 24-month window for total disclosed proceeds of A$21.0M, most recently a A$12.7M placement in September 2026. Options and rights on issue could convert into 45M new shares, equal to 17.4% of the current share count, of which 7% are in the money at the current share price; the nearest expiry falls in June 2027. The company has more than 4 quarters of funding at the recent spend rate. Two proposed securities issues (Appendix 3B) are pending, with the nearest expected issue date in October 2026.

AI-generated summary of this page's cited filings · updated 28 Oct 2026
Quick answers · 5

Is NYR raising capital?

Nyrada has 2 proposed issues of securities pending under Appendix 3B as at 28 Oct 2026; the most recent raise announced is Placement of $12.7M on 21 Sept 2026.

How much placement capacity does NYR have left?

About 89% of the 15% placement capacity left, about 11% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.

How much cash does NYR have?

In its quarterly cash report for the quarter ended 30 Sept 2026, Nyrada reported $13.7M of cash and estimated 11.2 quarters of funding available at its current rate of spending. That is the company's own estimate.

When do NYR's options expire?

Unexercised options and rights equal 17.4% of Nyrada's shares on issue; the nearest expiry is June 2027.

How much has NYR's share count grown?

Nyrada has 258.7M shares on issue as at 28 Oct 2026, up 42.0% over 24 months according to its Appendix 2A filings.

Get told when this changes
Get NYR alerts
Free for up to 2 companies. A daily email when NYR raises money, files a new share issue, drops below 2 quarters of cash or moves risk level.
17.4%
Options & rights overhang
6.8%
In the moneyAn option whose exercise price is below the last closing share price, so converting it pays. These are the options most likely to become new shares soon. supply
1
Raises · last 12 months
10.9 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 258.7M per ASX (delayed) (snapshot 28 Oct 2026).
220M240M260MDec 24Nov 25Oct 26Cash raise · 21 Sept 2026Cash raise · 4 Aug 2025258.7M

Cash runway

10.9 qtrs OURS
More than four quarters of funding at the recent spend rate.
Funds operations to about July 2029 at the reported spend rate.
$13.3M cash after burn.
FILED 11.2 qtrs · $13.7M cash · quarter ended 30 Sept 2026
OURS our estimate, carried to todayOURSOur estimate for today. We take the cash in the company’s latest cash report, deduct spending since at its reported rate, and, for quarterly filers, add raises announced after it. It moves daily; announced money may not all be received yet.$13.7M cash at 30 Sep 2026 − $0.4M spent ($1.2M a quarter × 28 days) = $13.3M left → 10.9 qtrsFILED as the company reportedFILEDAs the company stated it in its latest cash report. Dated to the end of that period, it does not change until the next report.
Free account
15 cash reports on record — Cash runway history
Cash, net spend and cover trend from every Appendix 4C/5B and 4D/4E on record up to 30 Sept 2026.
Free account: 2 full company unlocks every month, no card.
Unlock NYR freeSee plans

Issuance timeline

Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
25 Sept 20262A · quoted issueNYR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED258.7MAppendix 2A
24 Aug 20262A · quoted issueNYR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED247.6MAppendix 2A
30 June 20262A · quoted issueNYR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED245.7MAppendix 2A
30 June 20263H · cancellationNYR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED245.5MAppendix 3H
29 June 20262A · quoted issueNYR : CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED246.9MAppendix 2A
Free account
46 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Unlock NYR freeSee plans

Securities on issue over time

Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.

Free account
Securities on issue, by class
How the share count and each option and rights class moved, month by month, with every number in a table.
Free account: 2 full company unlocks every month, no card.
Unlock NYR freeSee plans

Capital raises

2 cash raises in the last 24 months · 1 in the last 12 months

every 13.6 monthsaverage gap between raises
1.2 monthssince the most recent
4 Aug 2025 – 21 Sept 2026first to most recent in this window
$12.7M
Placement
At 62.0c, 15.1% below the last close
21 Sept 2026 ACTIVE
Free account
10 issues (incl. 6 exercises or conversions) on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Unlock NYR freeSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

10.3M of option supply could convert within 12 months — 4.0% of shares on issue
10.3M in the money, expiring in the window
2 proposed issues (Appendix 3B) also pending — not counted above; the securities each would add are in the calendar below.
Out-of-the-money options are excluded — at today’s price they expire rather than convert. So is condition-triggered supply, which has no expiry and no price, and convertibles that convert on their own terms rather than on a date.
Free account
13 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Unlock NYR freeSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.

About 89% of the 15% placement capacity left — about 11% used by Appendix 3B filings in the last 12 months (estimate, as at 2026-10-28). Holders passed a ratification we could not match to exactly one filing, or whose number of shares the result does not state, and shares issued with holder approval are not added to the base, so the true headroom may be higher.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Unlock NYR freeSee plans

Pending proposed issues

2 proposed issues pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.
Paid plan
2 pending issues on record — Pending issue detail
Size, price, fees, broker and placement-capacity usage for each pending issue.
Unlocks on a paid plan
See plans

Options & convertible securities

17.4%
Options & rights overhang · of current shares
6.8%
In-the-money supply · at current price
45.1M
Potential new shares
June 2027
Nearest expiry
What a price move would switch on
22.6M45.1M$0.49 now0.25× today ($0.12) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.25) — 10.7M of the priced supply in the money, 4.1% of shares on issue0.75× today ($0.37) — 10.7M of the priced supply in the money, 4.1% of shares on issue1× today ($0.49) — 17.6M of the priced supply in the money, 6.8% of shares on issue1.25× today ($0.62) — 17.6M of the priced supply in the money, 6.8% of shares on issue1.5× today ($0.74) — 17.6M of the priced supply in the money, 6.8% of shares on issue2× today ($0.99) — 26.6M of the priced supply in the money, 10.3% of shares on issue3× today ($1.48) — 26.6M of the priced supply in the money, 10.3% of shares on issue5× today ($2.48) — 26.6M of the priced supply in the money, 10.3% of shares on issue10× today ($4.95) — 26.6M of the priced supply in the money, 10.3% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $0.49 today, 17.6M securities are in the money (6.8% of shares on issue). At double today’s price it is 26.6M (10.3% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 1.2M (2.7% of the supply above) states a nil exercise price — nothing is paid to convert it, so no share price switches it on or off. It is the flat band, and it is not part of the in-the-money figure.
  • 17.3M (38.3% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
CodeSecurityTypeExercise priceExpiryOn issueSource
NYRAJOptionsPrice-triggered$0.1430 June 20273.3MFiling
NYRAROptionsPrice-triggered$0.4522 Aug 20276.9MFiling
NYRAKOptionsPrice-triggered$0.2031 Dec 20271.8MFiling
NYRASOptionsPrice-triggered$0.8012 Nov 20293.0MFiling
NYRAVOptionsPrice-triggeredNil12 Nov 2030600kFiling
NYRATOptionsPrice-triggered$0.8012 Nov 20303.0MFiling
NYRAOOptionsPrice-triggered$0.1911 June 20311.6MFiling
NYRAWOptionsPrice-triggeredNil12 Nov 2031600kFiling
NYRAUOptionsPrice-triggered$0.8012 Nov 20313.0MFiling
NYRAPOptionsPrice-triggered$0.1911 June 20321.8MFiling
NYRAQOptionsPrice-triggered$0.1930 June 20332.1MFiling
NYRAIOptionsPrice-triggered, no exercise price stated——17.3MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.

Free account
12 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Unlock NYR freeSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
11 June 2026James BonnarBuy on-market4k——$2k3Y notice
11 June 2026James BonnarBuy on-market7k——$3k3Y notice
10 June 2026James BonnarBuy on-market6k——$3k3Y notice
Free account
39 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Unlock NYR freeSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

28 Oct 2026Securities Purchase Plan Results
19 Oct 2026$PQuarterly Activities Report and Appendix 4C
16 Oct 2026PROTECT-MI Phase IIa Clinical Trial Update No 3
13 Oct 2026$PNyrada Receives Positive FDA Feedback
12 Oct 2026$PAttaching Options Prospectus
12 Oct 2026Securities Purchase Plan Offer Booklet
8 Oct 20262026 AGM Letter to Shareholders, Notice of Meeting & Proxy
30 Sept 2026Nyrada US Patent for Xolatryp Granted
25 Sept 2026Cleansing Statement
25 Sept 2026Application for quotation of securities - NYR
21 Sept 2026Proposed issue of securities - NYR
21 Sept 2026Proposed issue of securities - NYR
21 Sept 2026Proposed issue of securities - NYR
21 Sept 2026Proposed issue of securities - NYR
21 Sept 2026$PCap Raise Deck-Building the Future of TRPC-based Therapies
21 Sept 2026$PNyrada Successfully Raises AU$12.0 Million Via Placement
17 Sept 2026$PTrading Halt
16 Sept 2026Investor Presentation- Evans&Partners Small Cap Healthcare
28 Aug 2026Change in substantial holding - M Azzi
24 Aug 2026Cleansing Statement

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.